Table 3.
Effect of different N stages on the risk of survival outcomes
| N stage | AJCC system | Proposed system | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OS | DFS | DFFS | OS | DFS | DFFS | |||||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| N0 | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | ||||||
| N1 | 2.50 (0.72–8.71) | 0.150 | 1.66 (0.75–3.65) | 0.208 | 1.52 (0.61–3.79) | 0.370 | 2.62 (0.77–8.91) | 0.123 | 1.38 (0.63–3.03) | 0.419 | 1.30 (0.53–3.23) | 0.569 |
| N2 | 4.02 (1.18–13.69) | 0.026 | 2.29 (1.05–4.98) | 0.038 | 2.16 (0.88–5.33) | 0.093 | 4.39 (1.26–15.34) | 0.020 | 3.53 (1.62–7.71) | 0.002 | 3.39 (1.38–8.31) | 0.008 |
| N3 | 7.72 (2.26–26.44) | 0.001 | 4.97 (2.28–10.83) | < 0.001 | 5.41 (2.22–13.16) | < 0.001 | 9.48 (2.75–32.69) | < 0.001 | 5.58 (2.52–12.38) | < 0.001 | 5.88 (2.37–14.61) | < 0.001 |
Abbreviations: AJCC American Joint Committee on Cancer, OS overall survival, DFS disease-free survival, DFFS distant failure-free survival, HR hazard ratio, CI confidence interval